
Join to view full profile
171 Ashley AveCharleston, SC 29425
Phone+1 843-792-1414
Dr. Hess is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Washington University/B-JH/SLCH ConsortiumFellowship, Hematology and Medical Oncology, 2013 - 2016
Loyola University Medical CenterResidency, Internal Medicine, 2010 - 2013
University of Missouri-Columbia School of MedicineClass of 2010
Certifications & Licensure
SC State Medical License 2016 - 2027
MO State Medical License 2013 - 2017
IL State Medical License 2010 - 2014
IL State Medical License 2010 - 2014
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 5 citationsOutcomes of bispecific antibodies after CAR T-cell failure for large B-cell lymphoma: results from the ABC consortium.Megan Melody, Natalie Grover, Stephanie Franco, Jason Romancik, Matthew Cortese
Blood Advances. 2026-01-13 - 9 citationsCamidanlumab tesirine for relapsed or refractory classic Hodgkin lymphoma: a phase 2 study.Alex F Herrera, Stephen M Ansell, Pier Luigi Zinzani, John Radford, Kami Maddocks
Blood Advances. 2025-12-09 - Real World Outcomes of Patients with Aggressive Lymphoma and Autoimmune Disease Treated with CART.Nicole J Altomare, Megan M Herr, Nisha M Nair, Deborah M Stephens, Jonathon B Cohen
Cancers. 2025-07-16
Abstracts/Posters
- Rapid and Durable Responses with the SYK/JAK Inhibitor Cerdulatinib in a PhaseBrian T. Hess, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- A Phase 2 Study of the Dual SYK/JAK Inhibitor Cerdulatinib Demonstrates GoodBrian T. Hess, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Clinical Utility of Chromosomal Microarray in Establishing Clonality and HighBrian T. Hess, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Press Mentions
Medical Student Carries Her Lymphoma Experience with HerMarch 15th, 2023
Pre-Exposure Prophylaxis with Tixagevimab-Cilgavimab Protects Blood Cancer Patients Against COVIDDecember 16th, 2022
Oncologist Leaves a Lasting Legacy at MUSC Hollings Cancer CenterJune 23rd, 2021
Grant Support
- Assessing Metabolically Reprogrammed and Purified CD19-CAR-T in NHL and CLLMEDICAL UNIVERSITY OF SOUTH CAROLINA2024–2029
- A Pilot Clinical Study for a Novel Bioresorbable Bone Adhesive to Evidence Improved Cranial Flap Fixation Based on Radiographic Imaging and Patient Reported OutcomesREVBIO, INC.2024–2026
- Commercialization of an Improved Treatment of Extremity Fractures Using a Regenerative Bone Adhesive to Accelerate Bone Healing in Aging PatientsREVBIO, INC.2023–2026
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: